Join Bullfrog AI's Exclusive Live Investor Webinar and Q&A Session on April 23

Group 1 - Bullfrog AI Holdings, Inc. is hosting a webinar on April 23, 2025, at 4:15 p.m. ET to discuss its innovative use of AI and machine learning in drug development [1] - The company's proprietary bfLEAP™ platform, developed at Johns Hopkins Applied Physics Lab, is designed to help biopharma firms uncover hidden biological insights and optimize clinical strategies using high-dimensional, multi-modal data [2] - Bullfrog AI's growth strategy includes driving recurring revenue through its scalable Data Networks platform while advancing a pipeline of licensed drug assets in collaboration with top-tier research institutions [2] Group 2 - The webinar will include a live question and answer session, allowing attendees to engage directly with the company's CEO, Vin Singh [3] - Interested participants can register for the free webinar and submit questions in advance via email or during the live event [3] - Bullfrog AI aims to streamline therapeutics development and reduce failure rates in clinical trials by leveraging causal AI and its bfLEAP™ platform [4]